Fear of COVID-19 among patients with prior SARS-CoV-2 infection : A cross-sectional study in Estonian family practices
BACKGROUND: Fear of coronavirus disease (COVID-19) has been associated with significant health effects.
OBJECTIVES: To assess COVID-19 fear and investigate factors associated with higher fear among COVID-19 survivors over 6 months after infection.
METHODS: Cross-sectional study using multistage sampling (family practices within the highest 5th percentile of numbers of SARS-CoV-2 infected patients and random sample of patients within these practices) performed from March 15 to 17 July 2021. Adult patients with a laboratory-confirmed history of COVID-19 were recruited for a self-administered 79-item questionnaire including demographics, self-rated health, physical activity, COVID-19 characteristics, severity and the fear of COVID-19 Scale (FCV-19S). Comorbidity data were extracted from Estonian Health Insurance Fund. Logistic regression models were used to evaluate factors associated with COVID-19 fear.
RESULTS: Of 341 participants included, 60% were women, 24.2% were hospitalised due to COVID-19 and 22.2% had long COVID, 143 (42%) participants reported high levels of fear (cut-off FCV-19S >17.8). Higher fear was associated with being female (aOR 2.12, 95% CI 1.14-3.95), age ≥61 years (aOR 3.23, 95% CI 1.28-8.16), two-member-households (aOR 3.70, 95% CI 1.40-9.77) physical inactivity 6 months prior to COVID-19 (aOR 3.53, 95% CI 1.26-9.95), and symptom severity during acute COVID-19. Long COVID was not associated with higher COVID-19 fear (aOR 1.82 95% CI 0.91-3.63).
CONCLUSION: Almost half of participants reported COVID-19 fear more than 6 months after infection. Greater fear was associated with sociodemographic factors, physical activity prior to COVID-19 and COVID-19 symptom severity. There is a need to target this population to develop appropriate interventions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
The European journal of general practice - 29(2023), 2 vom: 14. Dez., Seite 2195163 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Soomägi, Amanda [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 fear scale |
---|
Anmerkungen: |
Date Completed 08.06.2023 Date Revised 10.06.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/13814788.2023.2195163 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM357619315 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM357619315 | ||
003 | DE-627 | ||
005 | 20231226073004.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/13814788.2023.2195163 |2 doi | |
028 | 5 | 2 | |a pubmed24n1192.xml |
035 | |a (DE-627)NLM357619315 | ||
035 | |a (NLM)37259825 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Soomägi, Amanda |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fear of COVID-19 among patients with prior SARS-CoV-2 infection |b A cross-sectional study in Estonian family practices |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.06.2023 | ||
500 | |a Date Revised 10.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Fear of coronavirus disease (COVID-19) has been associated with significant health effects | ||
520 | |a OBJECTIVES: To assess COVID-19 fear and investigate factors associated with higher fear among COVID-19 survivors over 6 months after infection | ||
520 | |a METHODS: Cross-sectional study using multistage sampling (family practices within the highest 5th percentile of numbers of SARS-CoV-2 infected patients and random sample of patients within these practices) performed from March 15 to 17 July 2021. Adult patients with a laboratory-confirmed history of COVID-19 were recruited for a self-administered 79-item questionnaire including demographics, self-rated health, physical activity, COVID-19 characteristics, severity and the fear of COVID-19 Scale (FCV-19S). Comorbidity data were extracted from Estonian Health Insurance Fund. Logistic regression models were used to evaluate factors associated with COVID-19 fear | ||
520 | |a RESULTS: Of 341 participants included, 60% were women, 24.2% were hospitalised due to COVID-19 and 22.2% had long COVID, 143 (42%) participants reported high levels of fear (cut-off FCV-19S >17.8). Higher fear was associated with being female (aOR 2.12, 95% CI 1.14-3.95), age ≥61 years (aOR 3.23, 95% CI 1.28-8.16), two-member-households (aOR 3.70, 95% CI 1.40-9.77) physical inactivity 6 months prior to COVID-19 (aOR 3.53, 95% CI 1.26-9.95), and symptom severity during acute COVID-19. Long COVID was not associated with higher COVID-19 fear (aOR 1.82 95% CI 0.91-3.63) | ||
520 | |a CONCLUSION: Almost half of participants reported COVID-19 fear more than 6 months after infection. Greater fear was associated with sociodemographic factors, physical activity prior to COVID-19 and COVID-19 symptom severity. There is a need to target this population to develop appropriate interventions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 fear scale | |
650 | 4 | |a FCV-19S | |
650 | 4 | |a long covid | |
650 | 4 | |a post covid | |
650 | 4 | |a primary care | |
700 | 1 | |a Meister, Tatjana |e verfasserin |4 aut | |
700 | 1 | |a Vorobjov, Sigrid |e verfasserin |4 aut | |
700 | 1 | |a Suija, Kadri |e verfasserin |4 aut | |
700 | 1 | |a Kalda, Ruth |e verfasserin |4 aut | |
700 | 1 | |a Uusküla, Anneli |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The European journal of general practice |d 1998 |g 29(2023), 2 vom: 14. Dez., Seite 2195163 |w (DE-627)NLM094551847 |x 1751-1402 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2023 |g number:2 |g day:14 |g month:12 |g pages:2195163 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/13814788.2023.2195163 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2023 |e 2 |b 14 |c 12 |h 2195163 |